Common driver mutations (EGFR, ALK, BRAF, ERBB2, KRAS, MET, RET, and ROS1) analysis were performed in lung adenocarcinoma tissue samples from two PEAC patients (P08 and P10) using next-generation sequencing. This evidence concerns the gene EGFR and lung adenocarcinoma.